Predictive Biosciences
Lexington
About Predictive Biosciences
Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient. Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $68.1M
- Last round: Series Unknown (Jan 2013)
- Website: predictivebiosci.com
- Phone: (781)402-1780
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/predictive-biosciences-2248186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.